The cellular immune response seems to be important for the pathogenesis of reactive arthritis (ReA) and a bacteria-specific lymphocyte proliferation (LP) is often found in synovial fluid (SF ) of ReA patients. However, the role of the bacteria-specific LP in peripheral blood (PB) is less well defined. In this study, we investigated 215 paired samples of SF and PB from patients with ReA (n = 65), undifferentiated oligoarthritis (n = 133) and undifferentiated spondylarthropathy (n = 17) to analyse the LP in PB and SF in relation to time. In 24 out of 87 patients (27.6%) with a bacteria-specific LP in synovial fluid, a positive LP to the same bacterium was also found in PB. While a positive LP in SF was found most frequently in the first week of the arthritis, a positive LP in PB was detected in 45% of patients when investigated between weeks 2 and 4 after the onset of arthritis, but was rarely found very early and late in the course of the arthritis. The time point seems to be crucial for the investigation of an LP in PB in patients with ReA. Patients were recruited from four rheumatology antigen-specific lymphocyte proliferation (LP) to the clinics in the Berlin area. Paired samples of PB and triggering bacterium [7][8] [9] which is nearly always much SF were obtained from 215 patients with either ReA higher in synovial fluid (SF ) compared to peripheral (n = 65), UOA (n = 133) or uSpA (n = 17). Further blood (PB). Furthermore, the antigen-specific T-cell demographic characteristics are shown in Table I . The frequency determined by limiting dilution was also synovial lymphocyte proliferative responses of some of reported to be higher in SF than in PB [10] . Therefore, the patients have been reported before [10, 15, 16 ] . A the LP is rarely used in PB, mainly because in the puncture of a vein or joint was only performed when majority of patients this test is negative. necessary for diagnostic or therapeutic reasons. All Several studies claim that the antigen-specific LP in patients were treated with non-steroidal anti-PB may even be lower in patients with acute ReA, inflammatory drugs (NSAIDs) and some of the compared either with the same patients in remission patients also occasionally with intra-articular gluco- [11] or with patients infected with one of the ReAcorticoid injections and/or sulphasalazine. associated bacteria but not developing ReA [12, 13] 
R arthritis (ReA) occurs after a preceding LP in PB cells in these arthritides. The latter two groups have a clinical picture suggestive of ReA, but infection of the urogenital tract with Chlamydia trachomatis or of the gastroenteral tract with Yersinia, without a clear diagnosis of ReA. About one-third of patients with an antigen-specific LP in SF also showed Salmonella, Shigella and other bacteria. Recently, we could show that Chlamydia pneumoniae can also induce a cellular immune response to the same bacterium in PB. The highest proportion of an antigen-specific LP ReA, although this microbe seems to be less important [1] . ReA-associated bacteria have been detected in the in PB cells was found between the second and the fourth week after the first symptoms of ReA. joint by various techniques [2-6 ], indicating local persistence of bacterial antigen.
PATIENTS AND METHODS The concept that these antigens drive the local Patients immune response is supported by the finding of an Patients were recruited from four rheumatology antigen-specific lymphocyte proliferation (LP) to the clinics in the Berlin area. Paired samples of PB and triggering bacterium [7] [8] [9] which is nearly always much SF were obtained from 215 patients with either ReA higher in synovial fluid (SF ) compared to peripheral (n = 65), UOA (n = 133) or uSpA (n = 17). Further blood (PB). Furthermore, the antigen-specific T-cell demographic characteristics are shown in Table I . The frequency determined by limiting dilution was also synovial lymphocyte proliferative responses of some of reported to be higher in SF than in PB [10] . Therefore, the patients have been reported before [10, 15, 16 ] . A the LP is rarely used in PB, mainly because in the puncture of a vein or joint was only performed when majority of patients this test is negative. necessary for diagnostic or therapeutic reasons. All Several studies claim that the antigen-specific LP in patients were treated with non-steroidal anti-PB may even be lower in patients with acute ReA, inflammatory drugs (NSAIDs) and some of the compared either with the same patients in remission patients also occasionally with intra-articular gluco- [11] or with patients infected with one of the ReAcorticoid injections and/or sulphasalazine. associated bacteria but not developing ReA [12, 13] . Similar differences between SF and PB have been Definitions reported for the cellular immune response to Klebsiella Reactive arthritis was defined as oligoarthritis prepneumoniae in patients with ankylosing spondylitis ceded by a clear history of urethritis [urogenital (u) [14] .
ReA] or gastroenteritis [enteral (e) ReA] in the previous We have investigated paired samples of PB and SF 4 weeks. The triggering bacterium was identified either in 215 patients with ReA, undifferentiated oligoby a positive culture from stool or urethral swab, or arthritis ( UOA) and undifferentiated spondylarthroby a significantly elevated antibody titre early in arthpathies (uSpA) in order to clarify the relevance of the ritis [17] . UOA was defined as arthritis of unknown cause involving ≤4 joints including the knee, with no Bacterium-specific lymphocyte proliferation in those with ReA were not included in this study.
peripheral blood compared to synovial fluid Eighty-seven patients out of 215 showed a specific Cell separation and culture proliferation to an ReA-associated bacterium in SF.
Mononuclear cells (MNC ) from PB and SF were
In 24 out of these 87 patients (27.6%), an LP to the separated as described previously [15] , and triplicate same bacterium was also found in PB ( Fig. 1 ). Only wells were stimulated with the following agents in 87 two patients proliferated to a different bacterium in patients when this study was started: tissue culture PB compared to SF (data not shown). The highest medium alone (background proliferation); Chlamydia proportion of a positive LP in PB could be detected trachomatis serovar L1 (5 mg/ml ) Yersinia enterocolitin patients with uSpA followed by patients with ReA ica O.3 and O.9 (3 mg/ml ); tetanus toxoid (Behring, and UOA ( Fig. 1) . The percentage of patients positive Marburg, Germany; 1 mg/ml ); or pokeweed mitogen for one of the bacteria in their LP from SF differed (Sigma, Poole; 1 mg/ml ) [10, 15, 16 ] . In the remaining between the groups: Yersinia was most frequent for 128 patients, the following were used additionally as UOA patients, while in ReA and uSpA Chlamydia was antigens: Salmonella enteritidis (5 mg/ml ), Shigella found most often. In PB, Chlamydia were the predomflexneri (5 mg/ml ) and Campylobacter jejuni (5 mg/ml ).
inant bacteria detected by LP for all three patient All bacteria were heat inactivated at 60°C for 1 h. groups (Fig. 2) . Interestingly, the percentage of Wells were pulsed with [3H ]thymidine Shigella-specific LP in PB was higher with 56% (five (7.4 kBq/well ) for the last 18 h of culture and incorpout of nine patients) and the Yersinia-specific LP was oration measured at day 6 as described previously [15] .
lower with 11% (four out of 38 patients) in comparison Stimulation was carried out with whole bacteria.
to 35% in the Chlamydia group (14 out of 40 patients). Results are expressed as [3H ]thymidine incorporation in counts per minute (c.p.m.) or in stimulation indices (SI ). Stimulation indices, defined as the proliferation induced by an antigen divided by the background proliferation, were also used to define the positivity and specificity of responses as follows: in SF, SI ≥ 5 were considered positive. If responses to two or more antigens were positive, the highest SI had to be double the value of the next highest to be considered specific, otherwise this was regarded as a non-specific response. Subjects with SI < 5 for all pathogens were considered to be non-responders [15] . In PB, an SI ≥ 3 was regarded as positive. It was necessary to determine a different level for positivity in the two compartments since LP to specific and non-specific antigens is always (n = 9), weeks 2-4 (n = 37), weeks 5-26 (n = 59) and week >26 UOA, undifferentiated oligoarthritis; uSpA, undifferentiated spondyl-(n = 108). arthropathies.
Bacterium-specific lymphocyte proliferation at different
LP in PB is more likely to occur earlier in the course of arthritis except in the first week. Most of these time points
The comparison of bacterium-specific LP in SF and patients were followed up for at least 1 yr. There was no correlation between the results of the bacterium-PB became even more interesting when the time elapsed since the first symptoms of arthritis was analysed. Only specific LP in PB and the occurrence of remission or chronicity in the course of the patients' arthritis. a slight non-significant decrease in the percentage of bacterium-specific LP was found in SF over the first DISCUSSION half year of arthritis, with a peak in the first week. However, the maximum frequency of positive antigenIn this study, we showed that nearly 30% of 87 patients with a bacterium-specific LP in SF also had specific LP in PB was found when patients were investigated between 2 and 4 weeks after the onset of an LP to the same bacterium in PB. This figure comes close to that reported by Ford et al.
[20] in a much arthritis. This was significantly higher compared to the time after week 26 (P < 0.01) and non-significantly smaller study in which they detected such a systemic response in four out of 12 patients (33%). The propor-(most likely due to the small numbers) higher compared to the first week (P > 0.05) and the time after the tion of positive LP in PB was different for C. trachomatis (35.1%), Y. enterocolitica (11.4%) and S. flexneri fourth week (P > 0.05) (Fig. 3) . This difference was even clearer when the percentage of positive LP in PB (55.6%) in our study. The reason for this is not clear. That patients with Shigella-induced arthritis were was calculated only for those patients who showed an LP to the same bacterial antigen in SF: 45% (17/37) investigated more frequently earlier in the course of their arthritis compared to the other bacteria might be of patients were positive between weeks 2 and 4, 29% (16/59) were positive between weeks 5 and 26, but one explanation. We then analysed the cellular immune response in only 12% (1/9) and 11% (13/108) were positive in the first week and after week 26, respectively ( Fig. 3; relation to the duration of the arthritis. The highest frequency of a positive LP in SF was found in the first P < 0.05 for the comparison between weeks 2 and 4 and after week 26).
week. In contrast, nearly all of the LP to the same bacterium were negative in PB at the time of the first week, while there was a clear peak of positive LPs in Serial investigations of bacterium-specific lymphocyte proliferation in peripheral blood PB during the 2nd to 4th weeks. These results are of interest for two reasons. (i) They suggest that a sysIn 12 out of the 24 patients who showed a positive LP in PB and SF, an LP was performed in PB more temic response occurs at best only transiently during the initial gut or urogenital tract infection, and that than once. Only three patients (patients 2, 3 and 5) showed a specific LP to the same bacterium each time the cellular immune response starts locally after deposition of bacterial antigen in the joint. The systemic they were tested ( pared to SF over the following weeks also argues for because blood was not investigated at the optimal time. Future studies comparing the antigen-specific a predominant local cellular response. (ii) The bacterium-specific LP in PB is of no use for diagnostic cellular immune response between PB and SF should pay more attention to the time point of investigation. purposes during the first week of the arthritis or after the 26th week, while the best results-up to nearly Although the LP of PB MNC will not play a role in the diagnostic procedure in ReA because of a low 50% positivity-can be achieved after the first week.
The low systemic immune response to ReA-associsensitivity and an uncertain specificity, it might be useful for investigative purposes [23] [24] [25] . ated bacteria reported before suggests that this immune response is ineffective, and thus might fail to prevent R spreading of bacteria to the joint and the occurrence of arthritis [11] [12] [13] [14] 21] . The data reported here give ReA patients in whom bacteria can be detected in their 
